1-(4-Bromo-2,5-dimethoxyphenyl)ethanamine | 634150-94-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(4-Bromo-2,5-dimethoxyphenyl)ethanamine
• CAS: 634150-94-0
• 化学式: C₁₀H₁₄BrNO₂
• 分子量: 260.13
• InChiKey: JKOMOTQHGDWZAQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  44.5
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• IMMUNOASSAY FOR COMPOUNDS OF THE NBOME FAMILY
  申请人：Randox Laboratories Ltd.

  公开号：EP2950104B1

  公开（公告）日：2018-08-08
• COMPOSITIONS AND METHODS FOR TREATING OCULAR PATHOLOGIES
  申请人：The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College

  公开号：EP3618850A1

  公开（公告）日：2020-03-11
• COMPOSITIONS AND METHODS TO REDUCE PATHOGENESIS
  申请人：The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College

  公开号：US20200078335A1

  公开（公告）日：2020-03-12

  This invention is directed to compositions, methods and kits for ameliorating or reducing pathogenesis of a disease by administering to a subject a serotonin receptor agonist.
• [EN] COMPOSITIONS AND METHODS FOR TREATING OCULAR PATHOLOGIES<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE PATHOLOGIES OCULAIRES
  申请人：THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV AND AGRICULTURAL AND MECHANICAL COLLEGE

  公开号：WO2018204359A1

  公开（公告）日：2018-11-08

  This invention features compositions, methods, and kits for treating conditions associated with pathological ocular neovascularization, reducing scarring in the eye, treating dry eye, treating macular degeneration, and treating keratitis by administering a serotonin receptor agonist.
• [EN] COMPOSITIONS AND METHODS TO REDUCE PATHOGENESIS<br/>[FR] COMPOSITIONS ET PROCÉDÉS POUR RÉDUIRE LA PATHOGENÈSE
  申请人：THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV AND AGRICULTURAL AND MECHANICAL COLLEGE

  公开号：WO2018204354A1

  公开（公告）日：2018-11-08

  This invention is directed to compositions, methods and kits for ameliorating or reducing pathogenesis of a disease by administering to a subject a serotonin receptor agonist.